![Scott Platshon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Platshon
Directeur des opérations chez
PANACEA ACQUISITION CORP. II
Profil
Mr. Scott B. Platshon is a Chief Business Officer & Executive Vice President at Zymeworks, Inc., a Chief Operating Officer at Panacea Acquisition Corp.
II and a Partner at Ecor1 Capital LLC /Venture Capital/.
He is on the Board of Directors at Theravance Biopharma, Inc., Ajax Therapeutics, Inc. and Kumquat Biosciences, Inc. Mr. Platshon was previously employed as an Independent Director by Silverback Therapeutics, Inc., a Chief Operating Officer by Panacea Acquisition Corp., and a Partner by EcoR1 Capital, LLC.
He also served on the board at Terremoto Biosciences, Inc. He received his undergraduate degree from Stanford University.
Postes actifs de Scott Platshon
| Sociétés | Poste | Début |
|---|---|---|
| PANACEA ACQUISITION CORP. II | Directeur des opérations | 01/01/2021 |
| ZYMEWORKS INC. | Corporate Officer/Principal | 09/04/2026 |
| THERAVANCE BIOPHARMA | Directeur/Membre du Conseil | 23/09/2026 |
Ajax Therapeutics, Inc.
 Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Directeur/Membre du Conseil | 01/05/2021 |
Kumquat Biosciences, Inc.
 Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Directeur/Membre du Conseil | 01/02/2021 |
Anciens postes connus de Scott Platshon
| Sociétés | Poste | Fin |
|---|---|---|
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally. | Analyst-Equity | 01/03/2026 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Directeur/Membre du Conseil | 01/12/2024 |
| ARS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - |
Panacea Acquisition Corp.
 Panacea Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Directeur des opérations | - |
Formation de Scott Platshon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EcoR1 Capital, LLC
EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally. | Finance |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Commercial Services |
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Panacea Acquisition Corp.
Panacea Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Panacea Acquisition Corp. II
 Panacea Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
